BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27315758)

  • 1. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: Genetic diagnosis of primary aldosteronism.
    Zennaro MC; Jeunemaitre X
    Ann Endocrinol (Paris); 2016 Jul; 77(3):214-9. PubMed ID: 27315758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
    Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial hyperaldosteronism.
    Torpy DJ; Stratakis CA; Chrousos GP
    Braz J Med Biol Res; 2000 Oct; 33(10):1149-55. PubMed ID: 11004715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on Familial Hyperaldosteronism.
    Korah HE; Scholl UI
    Horm Metab Res; 2015 Dec; 47(13):941-6. PubMed ID: 26445452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism.
    Daniil G; Fernandes-Rosa FL; Chemin J; Blesneac I; Beltrand J; Polak M; Jeunemaitre X; Boulkroun S; Amar L; Strom TM; Lory P; Zennaro MC
    EBioMedicine; 2016 Nov; 13():225-236. PubMed ID: 27729216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New genetic insights in familial hyperaldosteronism.
    Jackson RV; Lafferty A; Torpy DJ; Stratakis C
    Ann N Y Acad Sci; 2002 Sep; 970():77-88. PubMed ID: 12381543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary aldosteronism: learning from the study of familial varieties.
    Stowasser M; Gordon RD
    J Hypertens; 2000 Sep; 18(9):1165-76. PubMed ID: 10994747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic and inherited mutations in primary aldosteronism.
    Fernandes-Rosa FL; Boulkroun S; Zennaro MC
    J Mol Endocrinol; 2017 Jul; 59(1):R47-R63. PubMed ID: 28400483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Chinese pedigree with glucocorticoid remediable aldosteronism.
    Liu X; Jin L; Zhang H; Ma W; Song L; Zhou X; Cai J
    Hypertens Res; 2021 Nov; 44(11):1428-1433. PubMed ID: 34462604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A de novo unequal cross-over mutation between CYP11B1 and CYP11B2 genes causes familial hyperaldosteronism type I.
    Carvajal CA; Stehr CB; González PA; Riquelme EM; Montero T; Santos MJ; Kalergis AM; Fardella CE
    J Endocrinol Invest; 2011 Feb; 34(2):140-4. PubMed ID: 20634641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.
    Carvajal CA; Campino C; Martinez-Aguayo A; Tichauer JE; Bancalari R; Valdivia C; Trejo P; Aglony M; Baudrand R; Lagos CF; Mellado C; Garcia H; Fardella CE
    Hypertension; 2012 Jan; 59(1):85-91. PubMed ID: 22083159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited Forms of Primary Hyperaldosteronism: New Genes, New Phenotypes and Proposition of A New Classification.
    Perez-Rivas LG; Williams TA; Reincke M
    Exp Clin Endocrinol Diabetes; 2019 Feb; 127(2-03):93-99. PubMed ID: 30199917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hyperaldosteronism.
    Stowasser M; Gordon RD
    J Steroid Biochem Mol Biol; 2001 Sep; 78(3):215-29. PubMed ID: 11595502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress on genetic basis of primary aldosteronism].
    Zhang H; Gu W; Jia MY
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 43(5):612-8. PubMed ID: 25372651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chimeric CYP11B1/CYP11B2 gene in glucocorticoid-insuppressible familial hyperaldosteronism.
    Ise T; Shimoda A; Takakuwa H; Kato T; Izumiya Y; Shimizu K; Suzuki T; Sasano H; Yokoyama H; Kobayashi K
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):131-4. PubMed ID: 11453962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial varieties of primary aldosteronism.
    Stowasser M; Gunasekera TG; Gordon RD
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1087-90. PubMed ID: 11903322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.
    Sertedaki A; Markou A; Vlachakis D; Kossida S; Campanac E; Hoffman DA; Sierra ML; Xekouki P; Stratakis CA; Kaltsas G; Piaditis GP; Chrousos GP; Charmandari E
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):845-851. PubMed ID: 27293068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyuric-polydipsic syndrome in a pediatric case of non-glucocorticoid remediable familial hyperaldosteronism.
    Mussa A; Camilla R; Monticone S; Porta F; Tessaris D; Verna F; Mulatero P; Einaudi S
    Endocr J; 2012; 59(6):497-502. PubMed ID: 22447138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GENETICS IN ENDOCRINOLOGY: The expanding genetic horizon of primary aldosteronism.
    Monticone S; Buffolo F; Tetti M; Veglio F; Pasini B; Mulatero P
    Eur J Endocrinol; 2018 Mar; 178(3):R101-R111. PubMed ID: 29348113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of primary aldosteronism.
    Funder JW
    Front Horm Res; 2014; 43():70-8. PubMed ID: 24943299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.